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ABSTRACT 
 
Pennsylvania Infectious Disease Surveillance Summary Report, 2007 
Jessica Linn Mahan, M.P.H. candidate 
Craig J. Newschaffer, Ph.D. 
 
 
 
 
Public health surveillance is the ongoing systematic collection, analysis, and interpretation of 
outcome-specific health data for purposes of improving health and safety.  The timely 
dissemination of these data to those responsible for preventing and controlling illness and injury 
are key to public health surveillance.  An Infectious Disease Surveillance Summary Report can 
provide healthcare organizations and providers, government and regulatory agencies, and other 
concerned individuals and groups with important statistical information about potentially 
preventable diseases.  The Pennsylvania Department of Health (PA-DOH) has not published an 
Infectious Disease Surveillance Summary Report since 1993.  Without a published report 
containing epidemiologic analysis of the raw count data, the healthcare community, the general 
public, and state policymakers lack the important information necessary for setting public health 
priorities.  This project consistedof secondary data analysis on several de-identified datasets 
provided by the PA-DOH.  The data were obtained through mandatory notifiable disease 
reporting laws and collected via the Pennsylvania Notifiable Electronic Disease Surveillance 
System (PA-NEDSS).  Subjects were Pennsylvania residents who incurred a reportable 
infectious disease for which they sought medical treatment from 2003 through 2007.  A concise 
and comprehensive annual report was created for the PA-DOH using these datasets.  This annual 
report includes the 2007 case count, 2007 incidence rate, 5-year (2003−2007) average case 
count, and 5-year (2003−2007) average incidence rate for each of the notifiable communicable 
diseases in Pennsylvania.  In addition, the report provides disease summaries, including 
descriptive epidemiology, and epidemiological trend information for selected notifiable diseases 
from 2003−2007.  Further, the high-profile outbreak investigations that were conducted by the 
PA-DOH in 2007 were detailed in the report.  The 2007 PennsylvaniaInfectious Disease 
Surveillance Summary Report will serve as a convenient and accessible summary of data by 
providing a snapshot of the patterns of disease in the state.  The report also provides an 
assessment of the efforts undertaken by the PA-DOH Division of Infectious Disease 
Epidemiology and highlights their annual accomplishments.  In addition, the annual report is an 
important reflection of the hard work and vigilance of healthcare providers and staff at 
laboratories and hospitals throughout the state.   
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Introduction 
Assessment of the population’s health is a core public health function, which is 
accomplished through public health surveillance.  Public health surveillance is the ongoing 
systematic collection, analysis, and interpretation of outcome-specific health data for purposes of 
improving health and safety.  The timely dissemination of these data to those responsible for 
preventing and controlling illness and injury are key to public health surveillance.Surveillance 
for communicable diseases is one type of public health surveillance.  Communicable disease 
surveillance is the continuous monitoring of the frequency and distribution of disease and death, 
due to infections that can be transmitted from people, animals, food, water, or the environment to 
humans.  Another important aspect of communicable disease surveillance is the monitoring of 
risk factors for infectious diseases.   
In the United States, state and local health departments are required, either by legislation 
or regulation, to perform communicable disease surveillance for the conditions that are 
considered notifiable within their particular state (CDC, 2008-1).  In the Commonwealth of 
Pennsylvania, the entity charged with this responsibility is the Pennsylvania Department of 
Health (PA-DOH), specifically the Division of Infectious Disease Epidemiology (henceforth 
referred to as the Division).The Division has the responsibility of detecting, preventing and 
controlling infectious illnesses of public health significance in Pennsylvania. 
The tracking of disease incidence and prevalence is essential to knowing who is affected 
by disease and where the problems are occurring (TDH, 2008).  Furthermore, the raw count data 
that are collected can then be analyzed for the purposes of assessing disease impact, determining 
trends in disease occurrence, characterizing affected populations, prioritizing control efforts, 
assuring public health interventions are implemented to prevent additional disease, and 
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evaluating prevention strategies.  An examination of these data over time is essential to knowing 
where prevention and control efforts need to be focused.These efforts to prevent and control 
infectious diseases will result in lower expenditures for health care and reduced disease burden. 
An Infectious Disease Surveillance Summary Report can provide healthcare 
organizations and providers, government and regulatory agencies, and other concerned 
individuals and groups with important statistical information about potentially preventable 
diseases.  However, the PA-DOH has not published an Infectious Disease Surveillance Summary 
Report since 1993.  Without a published report containing epidemiologic analysis of the raw 
count data, the healthcare community, the general public, and state policymakers lack the 
important information necessary for setting public health priorities.  The Director of the Bureau 
of Epidemiology at the PA-DOH believes that it is important to provide healthcare organizations 
and providers, government agencies, policy makers, and the citizens of the Commonwealth of 
Pennsylvania with information regarding infectious diseases that occur within the state each 
year, including the major disease outbreaks that occurred in the state.   
The PennsylvaniaInfectious Disease Surveillance Summary Report willserve as a 
convenient and accessible summary of data by providing a snapshot of the patterns of disease in 
the state.  The report also provides an assessment of the efforts undertaken by the Division and 
highlights their annual accomplishments.  In addition, the annual report is an important reflection 
of the hard work and vigilance of healthcare providers and staff at laboratories and hospitals 
throughout the state.  Without their participation in the notifiable disease reporting system, an 
accurate report of disease counts and trends within Pennsylvania would not be possible.The 
purpose of this report was to provide case counts and incidence rates for the more than 70 
reportable diseases and pathogens under surveillance in Pennsylvania in 2007 (see page 34 in the 
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Appendix), toprovidedisease summaries and trend information for certain highlighted diseases 
between 2003 and 2007, and to describe the notable outbreak investigations that were conducted 
in 2007.  This report is an important source of information regarding communicable diseases in 
Pennsylvaniafor healthcare providers, laboratory workers, infection control practitioners and 
public health officials.  In addition, this report demonstrates the impact of state disease control 
activities to the public and policy makers. 
 
Background and Significance 
According to the Centers for Disease Control and Prevention (CDC), a notifiable disease 
is one for which “regular, frequent, and timely information regarding individual cases is 
considered necessary for the prevention and control of the disease” (CDC, 2008-2, p. 2).  
National pubic health surveillance of communicable diseases began in 1878.  However, states 
and municipalities did not contribute to the weekly reporting and publication of notifiable 
diseases until 1893.  The first annual summary of the nationally notifiable diseases was 
published in 1912 and by 1928 all states, the District of Columbia, Hawaii, and Puerto Rico were 
participating in the national reporting.  In 1961, the CDC assumed responsibility for the 
collection and publication of data concerning nationally notifiable diseases (CDC, 2008-1).   
As global travel becomes increasingly common, the comparison of infectious disease data 
across cities, states, and countries is crucial.  The reporting of infectious diseases at the local 
level protects the public’s health by ensuring the proper identification and follow-up of cases.  In 
addition, public health authorities ensure that “persons who are already ill receive appropriate 
treatment; trace contacts who need vaccines, treatment, quarantine, or education; investigate and 
halt outbreaks; eliminate environmental hazards; and close premises where spread has occurred” 
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(CDC, 2008-2, p. 2).  Communicable disease surveillance helps public health workers monitor 
disease burden, recognize disease trends, assess the effectiveness of control and prevention 
measures, identify populations or geographic areas at high risk, allocate resources appropriately, 
formulate prevention strategies, and develop sound public health policies.  Monitoring this 
surveillance data further enables public health authorities to detect abrupt changes in disease 
occurrence and distribution, identify potential risk factors for infection, observe changes in 
healthcare practices, create and implement public health programs and interventions, and 
contribute data to monitor global trends (CDC, 2008-2). 
The CDC maintains a list of nationally notifiable diseases, which is periodically revised.  
As new pathogens emerge, diseases may be added to the list or alternatively, a disease may be 
deleted as its incidence declines.  The Council of State and Territorial Epidemiologists (CSTE), 
which is comprised of public health officials from state health departments, and the CDC 
collaborate each year at an annual conference in order to determine which diseases should be 
considered nationally notifiable.  While disease reporting is mandated at the state and local 
levels, state reporting to the CDC is voluntary.  State health departments determine which 
conditions their state considers notifiable; thus, the list of diseases considered notifiable varies by 
state and year (CDC, 2008-1).  In Pennsylvania, selected diseases are required by law (Pa Code § 
28.27) to be reported by health care providers, laboratories and hospitals (Commonwealth of 
Pennsylvania, 2008). 
In Pennsylvania, patient demographics, disease characteristics and risk factors, and other 
relevant data on each notifiable disease are collected and compiled from reports that are 
submitted by health care providers, laboratories and hospitals.  These data are reported to the 
PA-DOH through the Pennsylvania National Electronic Disease Surveillance System (PA-
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NEDSS).  PA-NEDSS is a passive reporting system that establishes a near real-time, secure 
communication link between laboratories, hospitals, individual medical practices, and the PA-
DOH.  PA-NEDSS was developed in order to improve the timeliness and accuracy of disease 
reporting and expand the public health infrastructure to improve response to possible 
bioterrorism attacks.  Since its implementation in 2003, its use has cut the average time from 
disease recognition to report received at the Division from weeks toless than two days for 
sentinel diseases such as Neisseria meningitidis and Salmonella (PA-DOH, 2008).  
This Infectious Disease Surveillance Summary Report used annual communicable 
disease reports from other state and municipal public health departments as templates.  Several 
reports that provided extensive and superior epidemiologic analysis of notifiable conditions were 
the states of Tennessee and Michigan, and the city of Philadelphia (TDH, 2008; MDCH, 2008; 
PDPH, 2008).  In addition, while the PA-DOH has not published an annual infectious disease 
report since 1993, they have worked on several incomplete drafts of the report for previous 
years, which were extremely useful when working on this project.   
 
Specific Aims 
The purpose of this project was to create a comprehensive and concise annual infectious 
disease report for the state of Pennsylvania.  This report will be published on the Department’s 
website in order to allow easy access for healthcare providers, public health professionals, and 
the general public throughout Pennsylvania.  The following aims were undertaken in order to 
produce the Pennsylvania Infectious Disease Surveillance Summary Report, 2007: 
• Create a table of 2007 Pennsylvania morbidity data (see Table 1 in the Appendix, page 
36) to include the following information for each reportable disease: Pennsylvania 2007 
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case count, Pennsylvania 2007 incidence rate, Pennsylvania 5-year (2003−2007) average 
case count, Pennsylvania 5-year (2003−2007) average incidence rate, U.S. 2007 case 
count, and U.S. 2007 incidence rate 
• Present disease summaries, including descriptive epidemiology, and perform the 
appropriate special analyses for selected reportable diseases 
• Provide epidemiological trend information for selected infectious disease surveillance 
data from 2003 through 2007 
• Describe the notable outbreak investigations conducted by the PA-DOH Division of 
Infectious Disease Epidemiology in 2007 
 
Research Design and Methods 
Overview 
This project consistedof secondary data analysis on several de-identified datasets 
provided by the PA-DOH.  The data were obtained through mandatory notifiable disease 
reporting laws and collected via the PA-NEDSS electronic disease reporting system.  A concise 
and comprehensive annual report (titled, “Pennsylvania Infectious Disease Surveillance 
Summary Report, 2007”) was created for the PA-DOH using these datasets.  This annual report 
includes the Pennsylvania 2007 case count, Pennsylvania 2007incidence rate, Pennsylvania 5-
year (2003−2007) average case count, and Pennsylvania 5-year (2003−2007) average incidence 
rate for each of the notifiable communicable diseases in Pennsylvania.  In addition, the report 
provides disease summaries, including descriptive epidemiology, and epidemiological trend 
information for selected notifiable diseases from 2003−2007.  Further, thehigh-profile outbreak 
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investigations that were conducted by the Division in 2007 were detailed in the report.  This 
report will be published on the PA-DOH website, providing pertinent information to healthcare 
providers and public health officials and demonstrating the impact of state disease control 
activities to policy makers and the public. 
Subjects 
Residents of the state of Pennsylvania were the source population for this project.  
Specifically, subjects were Pennsylvania residents who incurred a reportable infectious disease 
for which they sought medical treatment from 2003 through 2007.  The CDC requires that 
notifiable disease cases be reported by the state in which the individual maintains their 
permanent, legal residence.  Therefore, any non-Pennsylvania residents who had been diagnosed 
with a reportable infectious disease in Pennsylvania were not included in the analyses.  Similarly, 
allPennsylvania residents who incurred a notifiable infectious disease out-of-state were included 
in the analyses.  In other words, data used in this report were compiled per usual residence, 
regardless of the geographical place where the event occurred. Further, it was assumed that there 
was no migration into or out of Pennsylvania during the calendar year.  These criteria help 
ensure consistency for all calculations that use U.S. Census Bureau or Pennsylvania Bureau of 
Health Statistics data in the denominator.  
The PA-DOH received knowledge of notifiable infectious disease cases via reports sent 
to the PA-NEDSS reporting system by healthcare providers, hospitals and laboratories.  These 
data were stripped of identifiers before being given to the investigators for epidemiologic 
analysis.  For this report, it was assumed that the dataset contained full population data; thus, the 
subjects were not considered a sample, but a population.  Since the subjects were thought of as a 
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population and not a sample, sampling variation was not considered; therefore, there was no need 
to present standard errors and/or 95% confidence intervals. 
Study Variables and Methods of Data Collection 
Cases were defined and classified as such according to CDC case definitions and 
classifications for reporting and surveillance purposes (CDC, 2009). The CDC has three 
classifications for each notifiable condition: confirmed, probable and suspect.  In order to be 
counted as a case, the condition must meet CDC criteria for case classification.  For example, for 
some conditions, such as Shiga toxin-producing Escherichia coli (STEC), any person meeting 
the confirmed, probable or suspect case definition would be counted as a case.  For other 
conditions, such as Lyme disease, only those persons with confirmed disease would be counted 
as a case (CDC, 2009).  Several diseases were considered notifiable in Pennsylvania, but not at 
the national level and thus, did not have a case definition or classification.  For those diseases 
(such as influenza), the case definition and classification from the PA-DOH was used.   
While using CDC case definitions and classifications is the norm for state and local 
public health departments throughout the U.S., there is a slight problem with this method.  Each 
year, the CDC updates selected case definitions and classifications to more accurately reflect a 
case of the condition.  The most common reason that case definitions change is because of 
improved laboratory diagnostic tests.  While these updates may make disease reporting more 
precise, they also make it difficult to accurately interpret the trend of the disease over time.  
Specifically of concern to this annual report were conditions in which the case definition and/or 
classification changed between 2003 and 2007.  For instance,the case definition and 
classification for legionellosis was revised in 2005.  Prior to 2005, only confirmed cases were 
counted as cases for reporting and surveillance purposes, whereas in 2005 the case classification 
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changed to include suspect cases as well (CDC, 2009).  Thus, for all disease counts, the case 
definition and classification that was current in the year the data were collected was used and any 
disparity was noted in the report.  The case counting definition source and case classification 
status for all infectious diseases that are reportable in Pennsylvania are presented in Table 8 
(Appendix, page 65). 
The communicable diseases that are reportable in Pennsylvania are considered notifiable 
because of their ability to infect others, their public health significance, or both.  Healthcare 
providers, laboratories and hospitals are required to report all of the conditions listed on page 34 
to the PA-DOH within five workdays (unless otherwise noted for specific conditions).  Upon 
diagnosis of a notifiable disease case, the healthcare professional must electronically submit a 
form that provides details of the case via PA-NEDSS.  These data are then electronically stored 
by the PA-DOH for use in epidemiologic analyses.  In addition, the PA-DOH reports these data 
to the CDC due to their participation in the CDC’s voluntary notifiable disease reporting system.  
Every Friday, the Division compiles a list of all of the cases of nationally notifiable infectious 
diseases that have been reported in Pennsylvania that week and sends the list to the CDC for 
analysis and publication in the Morbidity and Mortality Weekly Report (MMWR).   
Hence, the data for this project had been previously collected via PA-NEDSS and stored 
in a database by the PA-DOH Bureau of Epidemiology.  When the cases are submitted to the 
PA-DOH via PA-NEDSS, they contain identifiers such as name, birth dateand address.  In order 
to maintain the confidentiality of individuals’ protected health information, the PA-DOH 
complied with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 
(CDC, 2003).  Thus, the data were stripped of identifiers and stored electronically for the 
secondary analyses specific to this project.  Therefore, all of the data that were used for this 
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project were de-identified, making themunable to be traced back to the original case.  The 
datasets did, however, maintain certain demographic characteristics such as age, gender, region 
and race/ethnicity.  This information was necessary in order to detect and document disease-
specific trends. 
The datasets that were used for epidemiologic analysis consisted of all notifiable 
infectious disease cases that were reported in the state of Pennsylvania from 2003 through 2007.  
One of the datasetscontained the data that PA-DOH sends to the CDC on a weekly basis for 
publication in the MMWR.  This dataset contained only the following variables for each case: 
diagnosis, event/disease code, age, gender, race/ethnicity, county, status (confirmed, probable, or 
suspect), outbreak-related (Y/N), MMWR week of diagnosis, event date, and MMWR year of 
diagnosis.  The race/ethnicity data were missing for many of the persons in this dataset, therefore 
no statistical analyses were done for race/ethnicity.  The second dataset used for this report 
contained more detailed information on certain pathogens responsible for disease outbreaks such 
asEscherichia coli, Salmonella, and Shigella.  In addition to containing all of the variables 
present in the MMWR dataset, this dataset also contained information on deaths, 
hospitalizations, species, serogroups and/or serotypes, symptoms, and the specific outbreak the 
case was related to if the case was part of an outbreak.  Additional information included in the 
report, such as outbreak investigation summaries, were obtained through interviews of PA-DOH 
staff, email correspondence, and/or internal departmental reports and files. 
Justification for Project 
Ultimately, this project serves several important functions.  First, the annual report 
provides health care organizations and providers, government and other agencies, and concerned 
citizens with an overview of selected notifiable infectious diseases reported in Pennsylvania in 
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2007.  Secondly, the report summarizes infectious disease surveillance data from 2003 through 
2007, providing important information on disease trends.  In addition, the report also provides an 
assessment of who is affected by disease and where disease is occurring.  By examining these 
data over time, the PA-DOH will be able to focus infectious disease prevention and control 
efforts where they are needed most throughout Pennsylvania.  In addition, the report describes 
the notable outbreak investigations conducted by the Division in 2007.  Lastly, the report serves 
as a source of important statistical information about potentially preventable diseases. 
Institutional Review Board Considerations 
As a secondary data analysis project, this study did not directly involve human subjects.  
There was no direct or indirect contact with any human subject and there was no additional data 
collection as part of this project.  The analyses and data are presented only in summary fashion.  
To maintain the confidentiality of subjects, the dataset was de-identified; thus, there was no way 
to link the data with the original participant.  All data provided to the investigators were kept 
confidential and were not shared with others.  In addition, any data that were kept off-site were 
stored on only one password-protected laptop.  Only the preceptor (who provided the data), the 
Drexel faculty advisor, certain PA-DOH employees, and the student had access to the data.  
The PA-DOH Institutional Review Board (IRB) reviewed the proposal to produce an 
annual report of statewide surveillance data, which included analyses of relevant epidemiological 
features of the diseases under surveillance.  Under CFR 45 Part 46 Section 101, this project was 
exempt from the requirement for institutional review because it exclusively used existing de-
identified records and data that were collected as part of mandated statewide disease monitoring 
and surveillance activities.  In addition, this project was submitted to the Drexel University IRB 
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and underwent an Exempt Category 4 review.  The Drexel University IRB approved the project 
protocol on January 12, 2009 (Protocol No: 18011). 
Data Analysis 
The first step in the data analysis was to create a table of Pennsylvania morbidity data 
from 2003 through 2007 (see Table 1 in Appendix, page 36).  First, the MMWR database was 
read into a SAS (SAS Institute, Cary, NC, 2001) statistical software program library.  Then, the 
data were checked to determine if there was any difference in event code number or event code 
name from 2003 to 2007.  In some instances, several event code numbers were combined into 
one disease code because they were essentially the same disease that had been coded differently 
between 2003 and 2007.  For instance, there was no code specifically for Shiga toxin-producing 
Escherichia coli(STEC) until 2006.  Prior to 2006, there were three different codes for 
Enterohemorrhagic Escherichia coli (EHEC).  However, as of January 1, 2006, those three codes 
were retired and the new code for STEC became exclusively used for reporting.  Thus, SAS code 
was written so that the program would recognize all disease observations with any of the four 
aforementioned event codes as STEC.  In addition, some diseases had multiple event code names 
for the same disease.  For instance, Vancomycin-intermediate Staphylococcus aureus had two 
different event code names: ‘VISA’ and ‘S AUR VAN INT’.  In instances like this, the multiple 
event code names for the same disease were combined into one event code name.  
Next, code was entered into SAS that told the program to only count disease observations 
as cases if the case status (confirmed, probable, or suspect) matched the case classification for 
reporting and surveillance purposes (see Table 8 in Appendix, page 65).  For instance, because 
the CDC recommends that only ‘confirmed’ Lyme disease cases be counted as actual cases, the 
code was written so that SAS would only recognize ‘confirmed’ Lyme disease observations as 
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cases and would disregard and observations that were ‘probable’ or ‘suspect’.  For those diseases 
for which the case classification had changed between 2003 and 2007, special code was written 
in order to count observations as cases according to the case classification that was current in the 
year the data were collected.  For instance, the legionellosis case classification for reporting and 
surveillance purposes changed from only ‘confirmed’ cases prior to 2005, to ‘confirmed’ and 
‘suspect’ cases in 2005.  Thus, code was written in order to allow SAS to only count ‘confirmed’ 
legionellosis cases in 2003 and 2004, and to count both ‘confirmed’ and ‘suspect’ cases from 
2005 to 2007. 
Next, code was entered into SAS to calculate the 2007 incidence rate for each disease, 
which was calculated as follows: 
 
Then, code was entered into SAS to calculate the average number of cases of each 
disease per year from 2003 through 2007, which was calculated as follows: 
 
 Lastly, code was entered into SAS to calculate the 5-year (2003−2007) average incidence 
rate for each notifiable condition, whichwas calculated as follows: 
 
2007 Annual IncidenceRate: 
Total Reported Cases of Disease in PA for 2007     x  100,000 
Total PA Population for 2007 
Five-Year (2003−2007) AverageCase Count: 
Total Number of Reported Cases of Disease in PA (2003−2007)  
                                                  5 
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All of the above calculations, in addition to all of the rate calculations done throughout 
the entire report, were done using Pennsylvania county population estimates from the U.S. 
Bureau of the Census. The Census Bureau calculates the total population of the state of 
Pennsylvania by summing all of the county population estimates.  The Pennsylvania Bureau of 
Health Statistics and the Pennsylvania State Data Center then use the Census Bureau county 
population estimates as controls to create the characteristics by age, sex, and race for the entire 
state and also for several counties.  For animal rabies cases,the crude incidence rate was 
calculated using the human population, as it is unknown how many animals reside in a particular 
geographic area.  The population estimates are as of July 1 for the intercensal years of 
2003−2007.  All population data presented and/or used in this report are U.S. Bureau of Census 
enumerated population figures as of April 1 of the Census year.   This information can be 
retrieved from the Census Bureau website at http://www.census.gov/popest/counties/CO-
EST2007-01.html (US Census Bureau, 2008).  The population data that was used to calculate 
rates can be found in the Appendix on page 62. 
Only a fraction of the more than 70 reportable conditions in Pennsylvania were 
highlighted in the annual report.  The conditions that are discussed in depth were chosen based 
on several criteria.  First, the condition must have been of interest to the state or the PA-DOH.  
Second, the condition must be of current public health importance.  Third, there must have been 
significant or surprising trends in any of the factors affecting disease (i.e., age, gender, 
Five-Year (2003−2007) Average IncidenceRate: 
Average PA Case Count (2003−2007)x  100,000 
 Average Population of PA from 2003−2007 
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geographic location, seasonality, etc.).  Based on the aforementioned criteria, the following 
conditions were highlighted in the report: Haemophilis influenzae invasive disease, hepatitis A, 
hepatitis B, influenza, legionellosis, Lyme disease, meningococcal invasive disease, 
pertussis,salmonellosis, Shiga toxin-producing Escherichia coli,shigellosis and West Nile virus.  
For each disease summary, a link to the disease fact sheet available on the PA-DOH website was 
provided.  This fact sheet contained pertinent epidemiological information such as causative 
agent, mode of transmission, incubation period, signs and symptoms, etc.  In addition, a website 
link to the CDC case definition/classification that was current in 2007 was provided for each 
disease summary.  For instances where the case definition and/or classification had changed 
between 2003 and 2007, a brief statement detailing the change was also provided.  Also, when 
available, a website link to the Healthy People 2010 goal for each selected disease was provided 
as well.   
Epidemiological trends for gender, age, year, season, and geographic location were also 
mentioned for each disease summary, sometimes in graphical form.  There were several guiding 
principles used to determine the descriptive epidemiology that was presented for each disease 
summary.  First, the figures and/or tables that were presented for each disease summary were 
chosen based on an a priori knowledge of disease trends gathered from literature reviews.  For 
instance, it is well known that salmonellosis and influenza display seasonal trends and pertussis 
and legionellosis display age trends.  It was important to present these trends in a graphical 
manner in order to make them easily visible to the reader.  Whenever figures depicting age 
trends were presented in the report, they were presented as the incidence rate and number of 
reported cases by age group.  This decision was made because the age group that was most 
affected in terms of incidence rate was often not the same age group that was most affected in 
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terms of total number of cases.  For example, it was not unusual to see the less than one year-old 
age group most affected in terms of incidence rate, but the 1−4 year-old age group most affected 
in terms of total number of cases.  It was considered important to provide public health officials 
with both incidence rates and total numbers because then they have the appropriate information 
to determine whether they want to target public health interventions to the age group where the 
incidence rate is highest or to the age group where they can impact the greatest number of at-risk 
individuals. 
Second, much of the descriptive epidemiology that was presented for each disease 
summary was information that staff at the PA-DOH specifically wanted to include in the report.  
For instance, PA-DOH staff thought it was important to include a frequency table of Salmonella 
serotypes and a figure showing the number of children under the age of five years who had 
haemophilis influenzae invasive disease, type B.  Lastly, the following information was 
presented for each disease summary (when available), either graphically or in bulleted form: 
2007 case count, 5-year (2003−2007) average case count, 2007 incidence rate, 5-year 
(2003−2007) average incidence rate, gender breakdown, age range and median, age group most 
affected (in terms of both incidence rate and case count), month in which the number of cases 
reached a peak, and geographic trends.  It is important to note that for several disease summaries 
the aforementioned epidemiological trend information is not presented (i.e., the incidence rates 
and case counts are not presented for influenza and the age and gender trends are not presented 
for West Nile virus).  This information is missing because of a lack of data necessary to calculate 
these trends, not because the information was considered unimportant. 
All statistical analyses were done using SAS version 9.1.  All maps were created using 
Epi Info version 3.5.1 and all other figures were created with Microsoft Excel 2008. 
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Results 
See the Pennsylvania Infectious Disease Surveillance Summary Report, 2007 in the Appendix on 
page 24. 
 
Discussion 
This project has several limitations.  First, PA-NEDSS is a passive reporting system, 
meaning that it is dependent on the appropriate persons reporting into the system.  Disease 
identification and reporting are dependent on many factors, including access to, and use of, 
health care; use and accuracy of diagnostic testing, and submission of disease reports by health 
care providers.  It is assumed that only a fraction of cases of these diseases are reported to the 
Department, although the degree of underreporting likely varies by disease.This underreporting 
will lead to an underestimation of the incidence and prevalence of the condition because an 
assumption implicit in the calculation of cumulative disease incidence is that all cases have been 
accounted for.  Furthermore, it is not only healthcare professionals that underreport cases of 
disease; patients underreport disease as well.  For instance, many people who contract a mild 
case of food poisoning due to exposure to Salmonella never seek medical treatment and, 
therefore, are never reported as a case.  Thus, if a patient does not seek medical treatment, they 
never enter the system as a case, leaving an observed case count that is less than the true count.  
In addition, misdiagnosis can lead to incorrect disease reporting, particularly underreporting.  For 
example, a patient that presents with symptoms of a foodborne illness may sometimes be 
diagnosed with the flu or some other gastrointestinal infection.  Therefore, the necessary 
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laboratory testing will not be ordered, so the case will not be confirmed as a foodborne illness 
and reported to the PA-DOH. 
Another weakness, which was previously mentioned above, is that certain CDC case 
definitionsand/or classifications changed between 2003 and 2007.  In instances where the case 
definition became broader (i.e., the definition now includes probable and/or suspect cases, in 
addition to confirmed) since 2003, any comparison of the incidence of the disease over time 
could be misleading.  The data may seem to indicate an increase in the incidence of the disease 
over time when, in truth, there is no increase.  Similarly, the case definitions that have become 
more specific since 2003 may indicate a decrease in the incidence of the disease over time, 
which may be inaccurate.  While any disparity in case definitions and/or classifications between 
2003 and 2007 was noted in the report, it is difficult to know with certainty whether changes in 
disease occurrence were true changes or simply the result of different reporting criteria or better 
laboratory diagnostic tests. 
Lastly, the small number of cases of certain notifiable diseases could cause a problem 
when attempting to interpret the data and determine disease trends.  Rates (or percentages) based 
on small numbers of events over a specified period of time or for a sparsely populated 
geographic area should be of particular concern and used cautiously.  The ability to generalize 
findings is limited for conditions with a small number of cases because there may be fluctuations 
in the magnitude of rates across groups or years that are purely due to chance.  When dealing 
with diseases with small case count, the addition or subtraction of only a few cases can have a 
large relative impact on the rate.  Thus, the results of the analyses of conditionswith a small case 
count should be interpreted with caution. 
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It is important to note the reason that crude rates were presented in this report, as opposed 
to adjusted rates.  Crude rates are the true, actual rates in the population.  When comparing the 
crude rates from different populations or different years, the rates may differ purely because of 
differences in the demographic composition of the populations being compared; not because of a 
true difference in disease occurrence.  Adjustment is often done to account for these 
confounders; that is, to account for the differences in characteristics related to disease risk across 
populations.  Adjustment was not done in this report because the population of Pennsylvania did 
not significantly change from year to year for any of the common factors related to infectious 
disease risk, such as age and gender.  Between 2003 and 2007, the age and gender profile of 
thePennsylvania population remained steady, with no significant differences observed.  
Similarly, the age and gender composition of the 2007 Pennsylvania population was highly 
comparable to that of the 2007 U.S. population, 2000 U.S. population, and 2000 Pennsylvania 
population.  Thus, it was determined that adjustment was not necessary for the rates presented in 
this report. 
Underreporting most likely affects the majority of reportable disease case counts and 
certainly warrants caution when interpreting disease trends.  However, the assumed 
underreporting of a certain disease does not necessarily negate the observed trends in disease 
frequency and occurrence.  For instance, some diseases, such as influenza, are known to be 
severely underreported due to the mild symptoms that cases frequently exhibit.  Despite severe 
underreporting, there are still a large number of influenza cases reported to the PA-DOH each 
year because influenza is an extremely common disease.  If one assumes that there is no 
difference between the cases that are reported and the cases that are not reported, then the 
observed epidemiological trends (even for a small fraction of the true number of cases) will still 
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be valid.  It is hard to determine whether or not the unreported cases differ from the reported 
cases and if so, how they differ.  However, it is important to highlight the disparities that were 
found for several infectious diseases in this report. 
For example, the data in this report showed that legionellosis disproportionately affects 
counties in the southwestern part of Pennsylvania more than counties in any other part of the 
state.  Particularly, Allegheny County had a higher case count and incidence rate than any county 
in the state.  One explanation for this observed geographic trend is that officials in Allegheny 
County look harder for legionellosis and order laboratory diagnostic tests on any individual that 
presents with symptoms of legionellosis, which are very non-specific.  Indeed, it is known that 
there is a physician in Allegheny County that is an expert on legionellosis and orders laboratory 
tests on any patient that presents with possible symptoms.  Despite this knowledge, it is difficult 
to know with confidence whether the high number of legionellosis cases reported in Allegheny 
County are the result of a true geographic disparity in legionellosis occurrence or simply the 
result of increased vigilance and laboratory testing.  In addition, there was a distinct gender 
difference observed with legionellosis.  In 2007, 63% of all reported legionellosis cases were 
male and the incidence rate in males exceeded that in females for all age groups, except the 
20−29 year-old age group.  Male gender is a known risk factor for legionellosis, but it is not clear 
why this gender difference exists.  It is possible that male gender is related to other risk factors 
for legionellosis such as smoking and diabetes and is thus, not truly a risk factor on its own.  It is 
also possible that because male gender is a known risk factor for legionellosis that legionellosis 
is suspected more often in males who present with symptoms than in females who present with 
similar symptoms.  Thus, if physicians differentially order legionellosis diagnostic tests for 
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males, the disease is more likely to be diagnosed and reported in males, although this may not 
reflect a true increased incidence in males. 
Data in this report also show that shigellosis disproportionately affects females and 
children.  The fecal-oral mode of transmission explains why children tend to be more affected by 
shigellosis than adults.  Children (especially young children that are not potty-trained) may not 
follow proper hand-washing and hygiene procedures as closely as adults do, and are therefore at 
increased risk of becoming infected with shigellosis.  Similarly, the observation that shigellosis 
tends to occur more in women can be explained the same way.  Since women are more likely to 
be caregivers (i.e., mothers and childcare workers) they are often exposed to Shigella through 
infected children and thus, they have an increased risk of becoming infected with shigellosis. 
 
Conclusions and Recommendations 
 This project provides timely summaries of epidemiologic content for those interested in 
the infectious disease burden in Pennsylvania.  The 2007 Pennsylvania Infectious Disease 
Surveillance Summary Report is of great value to the PA-DOH because it demonstrates the 
impact of disease control activities in Pennsylvania and also highlights the accomplishments of 
the Division.  In addition, the annual report is valuable to the community because it provides a 
snapshot of disease patterns throughout the state of Pennsylvania.  Knowledge of the frequency 
and distribution of disease and death due to infectious diseases can help focus prevention and 
control efforts throughout the state.  In addition, this knowledge can assist public health 
professionals and policymakersin setting public health priorities and in prioritizing public health 
education efforts and prevention strategies.  Further, this knowledge may also trigger future 
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research into the cause of certain demographic disparities in disease occurrence within 
Pennsylvania.  
This annual report is also valuable to the healthcare community because it serves as an 
important reflection of the hard work and vigilance of healthcare providers and staff at 
laboratories and hospitals throughout the state.  Without their active and continuing participation 
in the notifiable disease reporting system, an accurate report of disease counts and trends within 
Pennsylvania would not be possible.  The lack of a published report containing infectious disease 
case counts and analyses may lead disease-reporting participants to believe that notifiable disease 
surveillance and reporting is not important and/or that their participation in the reporting system 
is unnecessary.  This report will show disease-reporting participants the result and importance of 
their continued vigilance. 
Part of the reason past attempts at producing an annual report have failed is because the 
report was too bulky (often including summaries of every reportable disease) and provided too 
much non-pertinent information such as causative agent, mode of transmission, signs and 
symptoms, incubation period, etc.  The goal of this project was to produce a concise report, 
which would only include disease summaries and epidemiological trend information for those 
diseases that were of interest to the PA-DOH and/or were of public health significance in 
Pennsylvania.  Instead of including the disease background information within the report, 
website links were provided so that the reader could easy access the information.  By including 
website links to the background information instead of including it in the report, much of the 
bulk was eliminated.  This project has demonstrated that it is feasible for the PA-DOH to 
produce a comprehensive Infectious Disease Surveillance Summary Report each year that is 
concise and contains only noteworthy disease trends, analyses and outbreak investigations. 
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Purpose and Format of the Annual Infectious Disease Report 
 
The purpose of this report is to provide an overview of the notifiable infectious diseases that are 
reported in Pennsylvania by health care organizations, providers, and laboratories to local and 
state public health authorities for the purpose of disease prevention and control.  This report 
serves as a source of important statistical information about potentially preventable diseases.  In 
addition, this report will also provide an assessment of who is affected by these diseases and 
where disease is occurring.  By examining such information over time, we are able to more 
specifically focus infectious disease prevention and control efforts where they may be most 
beneficial throughout Pennsylvania.   
This report is a summary of surveillance data from 2003 through 2007.  The Disease Trends and 
Highlights section presents 2007 morbidity and incidence data for each notifiable infectious 
disease in Pennsylvania, along with 2003−2007 average case counts and rates.  In addition, this 
section documents the most notable epidemiological information on selected diseases for 2007.  
The Summary of Selected High-Profile Outbreak Investigations section describes the most 
notable outbreak investigations of 2007.  The Technical Notes section contains key terms and 
definitions, along with data that were used for calculations throughout the report. 
 
 
Notifiable Disease Reporting in Pennsylvania 
 
Selected diseases are required by law (PA Code, Title 28, Chapter 27) to be reported in 
Pennsylvania by health care providers, laboratories and hospitals.  The selected diseases are 
considered notifiable because of their ability to infect others, their public health significance, or 
both.  The infectious diseases designated as notifiable at the state level during 2007 are listed on 
page 4.  According to the Centers for Disease Control and Prevention, a notifiable disease is one 
for which “regular, frequent, and timely information regarding individual cases is considered 
necessary for the prevention and control of the disease”. 
 
Interpreting the Data 
 
These statistics are collected and compiled from reports that are submitted by health care 
providers, laboratories and hospitals.  Disease identification and reporting are dependent on 
many factors, including access to, and use of, health care; use and accuracy of diagnostic testing, 
and submission of disease reports by health care providers.  It is assumed that only a fraction of 
cases of these diseases are reported to the Department, although the degree of under-reporting 
likely varies by disease.  Disease reporting may also vary in completeness of the data.   
Please note that the case definition for each disease in this manual is for public health 
surveillance purposes only.  It is not intended for use in clinical diagnosis.   
Data in this report are presented by the date of report submission to the PADOH by the CDC’s 
Morbidity and Mortality Weekly Report (MMWR) week and year assigned by the state health 
department.  In addition, the data are reported by the patient’s residence at the time of diagnosis.  
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Also of importance, the data provided in this report are compiled from various program areas 
within the PADOH and, as such, may be different from other published reports.  For example, 
data may be aggregated by date of report versus date of occurrence or date of diagnosis.  
 
 
Pennsylvania National Electronic Disease Surveillance System (PA-NEDSS) 
 
PA-NEDSS is a new way to report diseases and investigative findings to the PADOH via the 
Internet, replacing the card and form-based methods.  As of November 16th, 2003, PA-NEDSS 
is the mandatory electronic disease reporting application for Pennsylvania.    
PA-NEDSS establishes a near real-time, secure communication link between laboratories, 
hospitals, individual medical practices, and the PADOH.  While the reporting process remains 
unchanged, PA-NEDSS seeks to improve the timeliness and accuracy of disease reporting and 
expand the public health infrastructure to improve response to possible bioterrorism attacks.  
For more information about electronic disease reporting regulations please review [33 Pa.B 
2439] www.pabulletin.com/secure/data/vol33/33-20/941.html .    
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Pennsylvania Department of Health List of Reportable Diseases 
 
1. AIDS (Acquired Immune Deficiency Syndrome) $ 
2. Amebiasis  
3. Animal bite# 
4. Anthrax # 
5. An unusual cluster of isolates  
6. Arboviruses (includes Colorado tick fever, Crimean-Congo 
hemorrhagic fever, dengue, Eastern equine encephalitis, St. 
Louis encephalitis, West Nile virus infection, Yellow fever, et 
al.) # 
7. Botulism (all forms) # 
8. Brucellosis  
9. Campylobacteriosis  
10. Cancer ^ 
11. CD4 T-lymphocyte test result with a count <200 
cells/microliter, or a CD4 T-lymphocyte % of <14% of total 
lymphocytes $ 
12. Chancroid  
13. Chickenpox (Varicella)  (Effective 1/26/05) 
14. Chlamydia trachomatis infections  
15. Cholera #  
16. Congenital adrenal hyperplasia (CAH) (<5y/old)  
17. Creutzfeldt-Jakob Disease  
18. Cryptosporidiosis  
19. Diphtheria #  
20. Encephalitis (all types) 
21. Enterohemorrhagic E. coli#  * 
22. Food poisoning outbreak # 
23. Giardiasis  
24. Gonococcal infections  
25. Granuloma inguinale  
26. Guillain-Barre syndrome  
27. Haemophilis influenzae invasive disease #  * 
28. Hantavirus pulmonary syndrome #  
29. Hemorrhagic fever # 
30. Hepatitis, viral, acute and chronic cases  
31. Histoplasmosis  
32. HIV $ 
33. Influenza (laboratory-confirmed only) 
34. Lead poisoning #  
35. Legionellosis #  
36. Leprosy (Hansen's Disease)  
37. Leptospirosis  
38. Listeriosis  
39. Lyme disease  
40. Lymphogranuloma venereum 
41. Malaria  
42. Maple syrup urine disease (MSUD) (<5y/old)  
43. Measles (Rubeola) #  
44. Meningitis (all types--not limited to invasive Haemophilis 
influenzae or Neisseria meningitidis)  
45. Meningococcal invasive disease #  * 
46. Mumps  
47. Perinatal exposure of a newborn to HIV 
48. Pertussis (whooping cough)  
49. Phenylketonuria (PKU) (<5y/old)  
50. Plague #  
51. Poliomyelitis #  
52. Primary congenital hypothyroidism (<5y/old)  
53. Psittacosis (ornithosis)  
54. Rabies #  
55. Respiratory syncytial virus  
56. Rickettsial diseases/infections (includes Rocky Mountain 
Spotted Fever, Q fever, rickettsialpox, typhus, Ehrlichiosis)  
57. Rubella (German measles) and congenital rubella syndrome  
58. Salmonellosis  * 
59. Severe Acute Respiratory Syndrome (SARS) # 
60. Shigellosis  * 
61. Sickle cell hemoglobinopathies (<5y/old)  
62. Smallpox # 
63. Staphylococcal aureus, Vancomycin Resistant (VRSA) or 
Intermediate (VISA) invasive disease  
64. Streptococcal invasive disease (Group A)  
65. Streptococcus pneumoniae, drug resistant invasive disease  
66. Syphilis (all stages)  
67. Tetanus  
68. Toxic shock syndrome  
69. Toxoplasmosis  
70. Trichinosis  
71. Tuberculosis, suspected or confirmed active disease (all sites) 
including the results of drug susceptibility testing  
72. Tularemia  
73. Typhoid fever #
For healthcare practitioners and healthcare facilities, all diseases are reportable within 5 workdays, unless otherwise noted. 
#  Healthcare practitioners and healthcare facilities must report within 24 hours. 
For clinical laboratories, all diseases are reportable by next workday, unless otherwise noted. 
$  Clinical laboratories must report within 5 days of obtaining the test result.   
*  In addition to reporting, clinical laboratories must also submit isolates to the state Laboratory within 5 workdays of isolation. 
^  Hospitals, clinical laboratories, and healthcare facilities must report within 180 days. 
BLUE: Not currently reportable via PA-NEDSS 
 
Please note that certain broad categories such as #22 (Food Poisoning Outbreak) should be construed to mean all such illnesses, 
even if the etiology is either not otherwise listed here, or a specific etiology cannot be determined. Further, all disease 
outbreaks and/or unusual occurrences of disease are reportable within the Commonwealth. Finally, note that local jurisdictions 
may require reports of additional conditions not listed here within their jurisdictions.  
Rev. 08/06
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II. DISEASE TRENDS AND HIGHLIGHTS IN 2007
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Table 1. 2007 Pennsylvania Morbidity Data 
 
PA 5-Year Average (2003−2007) U.S. 2007 
Disease # Cases (2007) 
Incidence 
per 100,000 
Population 
(2007) # Cases/ 
Year 
Incidence Rate 
Per 100,000 
Population^ 
# Cases 
Incidence Rate 
Per 100,000 
Population 
AIDS (Acquired Immune 
Deficiency Syndrome) 1,289 10.4 1,330.8 10.7   
Amebiasis   35 0.3 26.2 0.2   
Anthrax   0 0.0 0 0.0   
Botulism, foodborne 1 0.0 0.4 0.0   
Botulism, infant 11 0.1 12.0 0.1   
Botulism, wound and 
unspecified 0 0.0 0 0.0   
Brucellosis   1 0.0 1.4 0.0   
Campylobacteriosis   1,363 11.0 1,389.0 11.2   
Chancroid  0 0.0 0.4 0.0   
Chickenpox (Varicella)+ 4,680 37.6 4,917 39.5   
Chlamydia trachomatis 42,469 341.6 38,906.6 313.4   
Cholera (Vibrio cholerae) 0 0.0 0 0.0   
Coccidioidomycosis* 2 0.0 2.4 0.0   
Creutzfeldt-Jakob Disease   1 0.0 1.8 0.0   
Cryptosporidiosis   939 7.6 371.4 3.0   
Cyclosporiasis* 7 0.1 17.8 0.1   
Dengue 17 0.1 4.8 0.0   
Diphtheria   0 0.0 0.2 0.0   
Ehrlichiosis, human 
granulocytic 1 0.0 1.4 0.0   
Ehrlichiosis, human 
monolytic 2 0.0 1.0 0.0   
Ehrlichiosis, unspecified 3 0.0 3.8 0.0   
Encephalitis, other 
arbovirus-related^^ 1 0.0 0.4 0.0   
Encephalitis, primary 22 0.2 29.2 0.2   
Encephalitis, West Nile** 5 0.0 36.2 0.3   
Encephalitis, unspecified 4 0.0 8.4 0.1   
Enterohemorrhagic E.coli, 
Shiga toxin-producing 
(combined E. coli O157:H7 
and non-O157)++ 177 1.4 190.4 1.5   
Enterohemorrhagic E. coli, 
group unknown 0 0.0 0.4 0.0   
Giardiasis 758 6.1 903.0 7.3   
Gonococcal infections 12,706 102.2 11,699.2 94.2   
Granuloma inguinale 0 0.0 0 0.0   
Guillain-Barre syndrome 44 0.4 44.2 0.4   
Haemophilis influenzae 
invasive disease 165 1.3 138.8 1.1   
Hantavirus pulmonary 
syndrome 0 0.0 0.4 0.0   
Hemolytic Uremic 
Syndrome (HUS)* 2 0.0 1.4 0.0   
^ Denominator for rate calculations is the average of 2003-2007 population data from the US Census Bureau. 
* Not reportable in PA, however information is still collected. 
+ Varicella (Chicken pox) became reportable 1/26/2005.  Data is for 2005−2007 only.  Denominator for rate calculation is the average of 
2005−2007 population data. 
^^ Includes the following types of arbovirus-related encephalitis (California, Eastern Equine, Lacrosse, St. Louis). 
** The West Nile encephalitis case definition became more specific in 2004, accounting for the decrease in the case count and incidence rate. 
++ Included Shiga toxin-positive, not serogrouped in above E.coli count. 
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Table 1. 2007 Pennsylvania Morbidity Data 
 
PA 5-Year Average (2003−2007) U.S. 2007 
Disease # Cases (2007) 
Incidence 
per 100,000 
Population 
(2007) 
# Cases/ 
Year 
Incidence Rate 
Per 100,000 
Population^ 
# Cases 
Incidence Rate 
Per 100,000 
Population 
Hepatitis A 96 0.8 275.6 2.2   
Hepatitis B, acute 188 1.5 226.2 1.8   
Hepatitis B, chronic+ 1,769 14.2 1,590.8 13.0   
Hepatitis B, perinatal 7 0.1 5.0 0.0   
Hepatitis C, acute 34 0.3 53.6 0.4   
Hepatitis C, past or present 
infection 10,353 83.3 10,246.0 82.5   
Hepatitis D 2 0.0 1.2 0.0   
Hepatitis E 4 0.0 2.6 0.0   
Histoplasmosis 14 0.1 12.0 0.1   
HIV  1,322 10.6 1,219.2 9.8   
Influenza A       
Influenza B       
Influenza, unspecified       
Kawasaki syndrome* 0 0.0 0 0.0   
Legionellosis^^ 320 2.6 299.8 2.4   
Leprosy (Hansen’s disease) 0 0.0 0.2 0.0   
Leptospirosis 1 0.0 1.4 0.0   
Listeriosis 61 0.5 60.8 0.5   
Lyme disease 3,994 32.1 4,046.0 32.6   
Lymphogranuloma 
venereum 0 0.0 0.2 0.0   
Malaria 44 0.4 44.4 0.4   
Measles (Rubeola) 3 0.0 2.8 0.0   
Meningitis, aseptic 476 3.8 604.8 4.9   
Meningitis, other 149 1.2 125.6 1.0   
Meningococcal invasive 
disease (Neisseria 
meningitides)** 54 0.4 60.2 0.5   
Mumps 23 0.2 34.0 0.3   
Pertussis (whooping cough) 386 3.1 479.8 3.9   
Plague (Yersinia pestis) 19 0.2 21.2 0.2   
Poliomyelitis 0 0.0 0 0.0   
Psittacosis (ornithosis) 0 0.0 1.0 0.0   
Q fever (Coxiella burnetii 
infection) 1 0.0 1.4 0.0   
Rabies, animal++ 439 3.5 438.8 3.5   
Rabies, human 0 0.0 0 0.0   
Respiratory syncytial virus 474 3.8 671.6 5.4   
Rickettsial infections, other 
and unspecified 8 0.1 7.4 0.1   
Rocky Mountain spotted 
fever 18 0.1 23.2 0.2   
Rubella (German measles) 0 0.0 0 0.0   
Rubella, congenital 
syndrome 0 0.0 0 0.0   
Salmonellosis 1,948 15.7 1,779.6 14.3   
Severe Acute Respiratory 
Syndrome (SARS) 0 0.0 0.6 0.0   
Shigellosis 287 2.3 338.0 2.7   
^ Denominator for rate calculation is the average of 2003-2007 population data from the US Census Bureau. 
* Not reportable in PA, however information is still collected. 
+ The hepatitis B, chronic case classification changed from confirmed prior to 2007 to confirmed and probable in 2007. 
^^ The Legionellosis case classification changed from confirmed prior to 2005 to confirmed and suspected in 2005. 
** The Meningococcal invasive disease case classification changed from confirmed and probable prior to 2005 to confirmed, probable and 
suspected in 2005. 
++ For animal rabies cases,the crude incidence rate was calculated using the human population, as it is unknown how many animals reside in a 
particular geographic area. 
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Table 1. 2007 Pennsylvania Morbidity Data 
 
PA 5-Year Average (2003−2007) U.S. 2007 
Disease # Cases (2007) 
Incidence 
per 100,000 
Population 
(2007) 
# Cases/ 
Year 
Incidence Rate 
Per 100,000 
Population^ 
# Cases 
Incidence Rate 
Per 100,000 
Population 
Smallpox 0 0.0 0 0.0   
Staphylococcus aureus, 
vancomycin-resistant 
invasive disease (VRSA) 0 0.0 0 0.0   
Staphylococcus aureus, 
vancomycin-intermediate 
invasive disease (VISA)+ 3 0.0 0.6 0.0   
Streptococcal invasive 
disease (Group A) 252 2.0 265.4 2.1   
Streptococcus pneumoniae, 
drug-resistant invasive 
disease 110 0.9 101.0 0.8   
Syphilis, early latent   239.6 1.9   
Syphilis, late clinical 14 0.1 6.6 0.1   
Syphilis, late latent 231 1.9 261.8 2.1   
Syphilis, neuro 0 0.0 8.6 0.1   
Syphilis, primary 82 0.7 59.8 0.5   
Syphilis, secondary 181 1.5 140.8 1.1   
Syphilis, unknown latency 19 0.2 24.8 0.2   
Tetanus 0 0.0 1.0 0.0   
Toxic shock syndrome, other 8 0.1 8.2 0.1   
Toxic shock syndrome, 
streptococcal 3 0.0 5.8 0.0   
Toxoplasmosis 53 0.4 50.8 0.4   
Trichinellosis 0 0.0 0.4 0.0   
Tuberculosis 276 2.2 320.2 2.6   
Tularemia 0 0.0 0.8 0.0   
Typhoid fever 10 0.1 10.4 0.1   
Vibriosis, non-cholera* 5 0.0 4.8 0.0   
West Nile fever** 5 0.0 22.4 0.2   
Yellow fever 0 0.0 0 0.0   
^ Denominator for rate calculation is the average of 2003-2007 population data from the US Census Bureau. 
* Not reportable in PA, however information is still collected. 
+ Information was not collected prior to 2004. 
** The West Nile fever case definition became more specific in 2004, accounting for the decrease in the case count and incidence rate. 
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HAEMOPHILIS INFLUENZAE INVASIVE DISEASE 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=248167 
Pennsylvania Healthy People 2010 Goal: Please see Objectives 14-01c and 14-22b at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/haemophiluscurrent.htm 
Descriptive Epidemiology: 
• In 2007, there were 94 female cases and 71 male cases of haemophilis influenzae 
invasive disease 
• In 2007, cases ranged from <1 to 101 years of age (median = 67 years) 
• Cases reported by month of onset reached a peak in March 2007 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. HAEMOPHILIS INFLUENZAE INVASIVE 
DISEASE: Number of reported cases, by month of onset -- 
Pennsylvania, 
2007
Figure 1. HAEMOPHILIS INFLUENZAE TYPE 
B: Number of confirmed cases in children <5 
years of age, by year -- Pennsylvania, 
2003−2007
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HEPATITIS A 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230429 
Pennsylvania Healthy People 2010 Goal: Please see Objective 14-06 at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisacurrent.htm 
Descriptive Epidemiology: 
 
• In 2007, there were 48 female 
cases and 48 male cases 
• In 2007, cases ranged from <1 
to 95 years of age (median = 
43.5 years) 
• There were 96 reported cases of 
hepatitis A in 2007, with a 5-
year (2003−2007) reference 
average of 275.6 cases per year 
• The 2007 incidence rate was 0.8 
cases per 100,000 persons, while 
the 5-year (2003−2007) average 
incidence rate was 2.2 cases per 
100,000 persons 
• From 2003 to 2007, the number 
of cases per year ranged from 67 
to 980, with the greatest number of cases reported in 2003.  This bulge was due to a 
foodborne outbreak associated with green onions at a restaurant 
• The <1and ≥80 year-old age groups were most affected in terms of incidence rate, while the 
50−59 year-old age group was most affected in terms of the total number of cases 
Figure 3. HEPATITIS A: Number of reported cases, by 
year -- Pennsylvania, 2003−2007 
 
Figure 4. HEPATITIS A: Incidence and number of reported cases, by age group -- 
Pennsylvania, 2007 
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HEPATITIS B 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=249245 
Pennsylvania Healthy People 2010 Goal: Please see Objectives 14-01d, 14-03 a−c and 14-22c 
at http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:Acute: http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisb2000.htm 
Chronic: http://www.cdc.gov/ncphi/disss/nndss/casedef/hepatitisbcurrent.htm 
*NOTE: The chronic hepatitis B case classification changed from only ‘confirmed’ prior to 2007 
to ‘confirmed’ or ‘probable’ in 2007. 
 
Descriptive Epidemiology: 
• In 2007, there were 188 acute cases, 1,769 chronic cases, and 7 perinatal cases 
• The 5-year (2003−2007) reference average for acute hepatitis B was 226.2 cases per year 
• The 2007 incidence rate of acute hepatitis B was 1.5 cases per 100,000 persons and the 5-
year (2003−2007) average incidence rate was 1.8 cases per 100,000 persons 
• In 2007, there were 86 female cases of acute hepatitis B and 102 male cases.  For chronic 
hepatitis B, there were 774 female cases and 986 male cases 
• There were 5 cases of acute pediatric (<19 years old) hepatitis B in 2007 
• In 2007, cases of acute hepatitis B ranged from <1 to 89 years of age (median = 40 years) 
• From 2003 to 2007, people ages 25−39 had the highest incidence rate of acute hepatitis B 
Figure 5. HEPATITIS B, ACUTE: Incidence, by age group -- Pennsylvania, 
2003−2007
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INFLUENZA 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230443 
Pennsylvania Healthy People 2010 Goal: Please see Objectives 14-29a and 14-29c at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Pennsylvania Weekly Flu 
Report:http://www.dsf.health.state.pa.us/health/cwp/view.asp?a=171&q=246529 
Descriptive Epidemiology: 
• In 2007, there were 489 female cases and 410 male cases
Figure 6. INFLUENZA: Number of reported cases, by MMWR 
week and season -- Pennsylvania, 
2003−2007
Figure 7. INFLUENZA: Number of reported cases, by week of first report and 
organism -- Pennsylvania, 
2006−2007
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LEGIONELLOSIS 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=249833 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/legionellosis_current.htm 
*NOTE: The case classification changed from only ‘confirmed’ prior to 2005 to ‘confirmed’ or 
‘suspect’ in 2005. 
Descriptive Epidemiology: 
• There were 320 cases of legionellosis in 2007, with a 5-year(2003−2007) reference 
average of 299.8 cases per year 
• The 2007 incidence rate was 2.6 cases per 100,000 persons and the 5-year (2003−2007) 
average incidence rate was 2.4 cases per 100,000 persons 
• Cases reported by month of onset reached a peak in August 2007 
• In 2007, 63% of the cases 
were males (202 male 
cases and 118 female 
cases) 
• In 2007, cases ranged 
from <1 to 96 years of age 
(median = 62 years), with 
the ≥80 year-old age group 
most affected in terms of 
incidence rate and the 
50−59 year-old age group 
most affected in terms of 
total numbers 
• Southwestern PA has been 
most affected, both in 
terms of total number of 
Figure 8. LEGIONELLOSIS: Incidence and number of 
reported cases, by age group and gender -- Pennsylvania, 
2007
 
Figure 9. LEGIONELLOSIS: Incidence rate (per 100,000 population), by county -- 
Pennsylvania, 2007 
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cases and incidence rates 
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LYME DISEASE 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230464 
Pennsylvania Healthy People 2010 Goal: Please see Objective 14-08 at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/lyme_disease_1996.htm 
 
Descriptive Epidemiology: 
• There were 3,994 confirmed cases of Lyme 
disease in 2007, with a 5-year (2003−2007) 
reference average of 4,046 cases per year 
• The 2007 incidence rate was 32.1 cases per 
100,000 persons 
• From 2003 to 2007, the number of cases per 
year ranged from 3,242 to 4,722, with the 
greatest number of cases reported in 2003 
• Cases reported by month of onset reached a 
peak in July 2007 
• In 2007, there were 1,808 female cases and 
2,179 male cases 
• In 2007, cases ranged from <1 to 95 years of 
age (median = 42 years), with the 40−49 year-
old age group most affected in terms of total number of cases and the 50−59 year-old age 
group most affected in terms of incidence rate 
• Southeastern PA has been most affected, both in terms oftotal number of cases and 
incidence rates 
Figure 10. LYME DISEASE. Number of 
reported cases, by year -- Pennsylvania, 
2003−2007
 
Figure 11. LYME DISEASE: Incidence rate (per 100,000 population), by county -- Pennsylvania, 2007 
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Figure 12. MENINGOCOCCAL INVASIVE 
DISEASE: Serogroups of laboratory-
confirmed cases -- Pennsylvania, 2003−2007 
 
 
 
*NG = Non-groupable 
MENINGOCOCCAL INVASIVE DISEASE 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=234559 
Pennsylvania Healthy People 2010 Goal: Please see Objective 14-07 at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/meningococcalcurrent.htm 
*NOTE: The case classification changed from ‘confirmed’ or ‘probable’ prior to 2005 to 
‘confirmed’, ‘probable’ or ‘suspect’ in 2005. 
Descriptive Epidemiology: 
• There were 54 cases of meningococcal invasive disease in 2007 (35 of which were 
laboratory-confirmed), with a 5-year (2003−2007) reference average of 60.2 cases per year 
• The 2007 incidence rate was 0.4 cases per 100,000 persons 
• From 2003 to 2007, the number of cases per year 
ranged from 54 to 81, with the greatest number 
of cases reported in 2003 
• Serogroup Y was the most common serogroup, 
accounting for 43.8% of all laboratory-confirmed 
cases from 2003−2007 
• In 2007, there were 27 female cases and 27 male 
cases 
• In 2007, the highest incidence of confirmed cases 
occurred in children <1 years old, who were 
affected at more than 10 times the rate of the next 
highest age group (1−4 year-olds) 
• In 2007, cases ranged from <1 to 88 years of age 
(median = 22 years), with the <1 year-old age 
group most affected, both in terms of the total 
number of cases and incidence rate
Figure 13. MENINGOCOCCAL INVASIVE DISEASE: 
Incidence and number of reported cases*, by age group -- 
Pennsylvania, 2007 
 
*Confirmed cases only(n=35) 
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PERTUSSIS 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230492 
Pennsylvania Healthy People 2010 Goal: Please see Objectives 14-01g and 14-22a at 
http://www.dsf.health.state.pa.us/health/lib/health/HP2010/HP2010-FA14PA.pdf 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/pertussis_current.htm 
Descriptive Epidemiology: 
 
• There were 386 reported cases of pertussis in 2007, with a 5-year (2003−2007) reference 
average of 479.8 cases per year 
• The 2007 incidence rate was 3.1 cases per 100,000 persons, while the 5-year (2003−2007) 
average incidence rate was 3.9 cases per 100,000 persons 
• From 2003 to 2007, the number of 
cases per year ranged from 352 to 
587, with the greatest number of 
cases reported in 2006 
• Cases reported by month of onset 
reached a peak in November 2007 
• In 2007, there were 215 female 
cases and 171 male cases 
• In 2007, cases ranged from <1 to 
83 years of age (median = 10 
years) 
• The 5−9 year-old age group was 
most affected in terms of the total 
number of cases, but the <1 year-
old age group was most affected 
in terms of incidence rate
Figure 14. PERTUSSIS: Number of reported cases, by 
month of onset -- Pennsylvania, 2007 
Figure 15. PERTUSSIS: Number of reported cases, 
by year -- Pennsylvania, 
2003−2007
Figure 16. PERTUSSIS: Incidence and number of 
reported cases, by age group -- Pennsylvania, 2007 
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SALMONELLOSIS 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230569 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/salmonellosis_current.htm 
*NOTE: The case definition changed in 2005, with no change in case classification. 
Descriptive Epidemiology: 
• There were 1,948 reported cases of salmonellosis in 2007, with a 5-year (2003−2007) 
reference average of 1,779.6 cases per year 
• Cases reported by month 
of onset reached a peak in 
July 2007 
• In 2007, there were 1,046 
female cases and 900 male 
cases 
• From 2003 to 2007, the 
number of cases per year 
ranged from 1,553 to 
2,026, with the greatest 
number of cases reported 
in 2004 
• In 2007, cases ranged from 
<1 to 98 years of age 
(median = 28 years) 
• The1−4 year-old age group 
was most affected in terms of the total number of cases, but the <1 year-old age group was 
most affected in terms of incidence rate 
Figure 18. SALMONELLOSIS: Incidence and number of reported cases, by age group* -- 
Pennsylvania, 2007 
 
*Of the 1,948 cases of salmonellosis, age was missing for 6 persons. 
Figure 17. SALMONELLOSIS: Number of reported cases, by 
month of onset -- Pennsylvania, 
2007
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Table 2. SALMONELLOSIS: The Top 20 Most Frequently Reported 
Serotypes in Pennsylvania, 2007 
Rank Serotype Number Reported Percent 
1 Enteriditis 502 26.7 
2 Typhimurium 436 23.2 
3 Newport 96 5.1 
4 I 4,[5],12:i:- 54 2.9 
5 Braenderup 43 2.3 
6 Heidelberg 42 2.2 
7 Paratyphi B variant 38 2.0 
8 Tennessee 37 2.0 
T-9 Oranienburg 31 1.6 
T-9 Thompson 31 1.6 
11 Montevideo 29 1.5 
12 Muenchen 28 1.5 
13 Javiana 26 1.4 
14 Schwarzengrund 25 1.3 
15 Litchfield 24 1.3 
16 Saint-Paul 20 1.1 
17 Agona 16 0.9 
18 Berta 14 0.7 
19 Infantis 13 0.7 
20 Senftenberg 12 0.6 
 Sub Total 1,517 80.6 
 All other serotyped 263 14.0 
 Unspecified/unknown 73 3.9 
 Rough, mucoid, and/or non-motile isolates 29 1.5 
 Sub Total 365 19.4 
 Total 1,882* 100 
*Number of laboratory-confirmed cases 
 
• In 2007, there were 39 outbreaks of salmonella reported and 10.5% (204) of all salmonellosis 
cases were outbreak-related  
• From 2003 to 2007, 803 cases were outbreak-related, with the largest number of outbreak-
related cases (372) occurring in 2004 
• From 2003 to 2007, the largest single outbreak occurred in 2004 and affected 259 persons.  
This outbreak was associated with a major convenience store chain 
• Enteritis and Typhimurium were the most common serotypes in 2007, accounting for just 
under 50% of all reported serotypes 
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SHIGA TOXIN-PRODUCING ESCHERICHIA COLI (STEC) 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230380 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/shiga_current.htm 
*NOTE: Prior to 2005, STEC was called EHEC 
Descriptive Epidemiology: 
• There were 177 reported cases of STEC in 2007, with a 5-year (2003−2007) reference 
average of 190.4 cases per year 
• The 2007 incidence rate was 1.4 cases per 100,000 persons, while the 5-year (2003−2007) 
average incidence rate was 1.5 cases per 100,000 persons 
• Cases reported by month of 
onset reached a peak in July 
2007 
• In 2007, there were 86 male 
cases and 91 female cases 
• In 2007, cases ranged from 
<1 to 88 years of age 
(median = 20 years) 
• The 1−4 year-old age group 
was most affected in terms 
of incidence rate, while the 
10−19 year-old age group 
was most affected in terms 
of the total number of cases 
 
 
 
 
Figure 20. SHIGA TOXIN-PRODUCING ESCHERICHIA COLI: Incidence and number 
of reported cases, by age group -- Pennsylvania, 
2007
Figure 19. SHIGA TOXIN-PRODUCING ESCHERICHIA 
COLI: Number of reported cases, by month of onset -- 
Pennsylvania, 
2007
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• From 2003 to 2007, there was one reported death due to STEC.  This death occurred in 2006 
in a child who had reported drinking unpasteurized milk and/or juice, a common source of E. 
coli 
• From 2003 to 2007, 268 people were hospitalized due to STEC.  57 of the hospitalizations 
occurred in 2007 
• In 2007, one person developed hemolytic uremic syndrome (HUS) and one person developed 
both HUS and thrombotic thrombocytopenic purpura (TTP), which are complications of 
STEC 
• There were 4 people who developed HUS and 1 person who developed both HUS and TTP in 
2006 
• There were no cases of HUS or TTP between 2003 and 2005 
• In 2007, there were 5 outbreaks of STEC reported and 16.8% (26) of all STEC cases were 
outbreak-related 
• From 2003−2007, 107 cases were outbreak-related, with the largest number of outbreak-
related cases (79) occurring in 2006 
• There were no outbreaks of STEC reported in 2004 or 2005  
• From 2003 to 2007, the largest single outbreak occurred in 2006 and affected 59 persons.  
This outbreak was associated with a major fast food restaurant chain 
• Serogroup O157 was the most common Shiga toxin-producing E. coli, accounting for more 
than 50% of all reported cases from 2003 to 2007
 
Table 3. SHIGA TOXIN-PRODUCING ESCHERICHIA COLI: Frequency of Serogroups, 2003−2007 
Serogroup Serogroup Percent Frequency Within Year (n) 
Total 
Within 
Serogroup 
Frequency 
of Serogroup 
(%), All 
Years 
 2003 2004 2005 2006 2007   
O103 0.0 (0) 0.0 (0) 0.8 (1) 0.0 (0) 0.7 (1) 2 0.3 
O157 32.8 (39) 28.8 (28) 69.8 (88) 68.0 (100) 70.9 (105) 360 56.5 
Shiga toxin 
(Non-O157) 0.0 (0) 2.1 (2) 15.9 (20) 9.5 (14) 21.0 (31) 67 10.5 
Unspecified 67.2 (80) 69.1 (67) 13.5 (17) 22.5 (33) 7.4 (11) 208 32.7 
Total 100 (119) 100 (97) 100 (126) 100 (147) 100 (148) 637 100 
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SHIGELLOSIS 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230576 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/shigellosis_current.htm 
*NOTE: The case definition changed in 2005, with no change in case classification. 
 
Descriptive Epidemiology: 
• There were 287 reported cases of shigellosis in 
2007, with a 5-year (2003−2007) reference average 
of 338 cases per year 
• From 2003 to 2007, the number of cases per year 
ranged from 88 to 977, with the greatest number of 
cases reported in 2003 
• In 2007, there were 167 female cases and 118 male 
cases.  Shigellosis tends to occur more in women 
because they are more likely to be caregivers and 
are often exposed through infected children 
• The 2007 incidence rate was 2.3 cases per 100,000 
persons, while the 5-year (2003−2007) average 
incidence rate was 2.7 cases per 100,000 persons 
• In 2007, cases ranged from <1 to 83 years of age 
(median = 8 years) 
• The 1−4 year-old age group was most affected, 
both in terms of total number of cases and 
incidence rate 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. SHIGELLOSIS: Incidence and number of reported cases, by age group* -- 
Pennsylvania, 2007 
 
*Of 287 cases of shigellosis, age was missing for 1 person. 
Figure 21. SHIGELLOSIS: Number 
of reported cases, by year -- 
Pennsylvania, 
2003−2007
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• In 2007, nearly 40% of shigellosis cases occurred in the month of November (109 cases) 
• In 2007, there were 2 outbreaks of Shigella reported and 17.4% (50) of all shigellosis cases 
were outbreak-related 
• From 2003−2007, 182 cases were outbreak-related, with the largest number of outbreak-
related cases (91) occurring in 2005 
• There were no outbreaks of Shigella reported in 2004 or 2006 
• From 2003 to 2007, the largest single outbreak occurred in 2005 and affected 75 persons 
• From 2003 to 2007, there were 3 deaths due to shigellosis.  All 3 deaths occurred in 2003 in 
children ages of 1−6.  All 3 children were infected in child care settings, which continues to 
be the most common source of Shigella infection 
• Sonnei was the most common species of Shigella, accounting for more than 75% of all 
reported cases from 2003 to 2007 
Table 4. SHIGELLOSIS: Frequency of Species, 2003−2007 
Species Species Percent Frequency Within Year (n) 
 Total 
Within 
Species 
Frequency 
of Species 
(%), All 
Years 
 2003 2004 2005 2006 2007   
Boydii 0.1 (1) 1.8 (2) 0.4 (1) 3.2 (3) 1.0 (2) 9 0.6 
Coli 0.0 (0) 0.9 (1) 0.0 (0) 0.0 (0) 0.5 (1) 2 0.1 
Dysenteraie 0.3 (2) 3.7 (4) 0.4 (1) 1.1 (1) 0.0 (0) 8 0.6 
Flexneri 3.0 (24) 32.1 (35) 16.3 (38) 38.7 (36) 8.1 (17) 150 10.4 
Sonnei 92.9 (748) 57.8 (63) 42.1 (98) 46.2 (43) 67.4 (141) 1,093 75.4 
Unspecified 3.7 (30) 3.7 (4) 40.8 (95) 10.8 (10) 23.0 (48) 187 12.9 
Total 100 (805) 100 (109) 100 (233) 100 (93) 100 (209) 1,449 100 
Figure 23. SHIGELLOSIS: Number of reported cases, by month of onset -- 
Pennsylvania, 
2007
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WEST NILE VIRUS 
 
Fact Sheets: 
Background Info (agent, mode of transmission, symptoms, treatment, prevention): 
http://www.dsf.health.state.pa.us/health/cwp/view.asp?A=171&Q=230611 
Case Definition:http://www.cdc.gov/ncphi/disss/nndss/casedef/arboviral_current.htm 
*NOTE: The case definition became more specific in 2004, but there was no change in case 
classification. 
State Surveillance:http://www.westnile.state.pa.us/ 
Descriptive Epidemiology: 
• From 2003 to 2007, the number of cases per year ranged from 9 to 237, with the greatest 
number of cases reported in 2003 
• From 2003 to 2007, cases reported 
by month of onset reached a peak in August 
• There were 10 reported cases of 
West Nile virus in 2007, with a 
5-year (2003−2007) reference 
average of 59.2 cases per year 
• The 2007 incidence rate was 
0.08 cases per 100,000 persons, 
while the 5-year (2003−2007) 
average incidence rate was 0.48 
cases per 100,000 persons 
• In 2007, 5 people with West 
Nile virus infection developed 
encephalitis/meningitis and 
there were 2 fatalities 
• From 2003−2007, there were 14 
fatalities from West Nile virus
Figure 24. WEST NILE VIRUS: Number of reported 
cases, by month of onset -- Pennsylvania, 
2003−2007
Figure 25. WEST NILE VIRUS: Virus activity, by county -- Pennsylvania, 2007 
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III. SUMMARY OF SELECTED HIGH-PROFILE OUTBREAK INVESTIGATIONS 
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Foodborne botulism 
Foodborne botulism is a potentially lethal neuroparalytic disease caused by ingesting foods 
contaminated with neurotoxins of the anaerobic, spore-forming bacterium Clostridium 
botulinum.  Botulism is a very severe illness, whose recovery often takes weeks to months.  The 
canning and fermentation of foods are particularly conducive to creating anaerobic conditions 
that allow C. botulinum spores to germinate.  Because of the severity of the disease⎯and its 
potential for use as a biological weapon⎯every case of botulism is investigated and treated as a 
public health emergency. 
The PADOH worked closely with the Pennsylvania Department of Agriculture on the year's only 
confirmed case of foodborne botulism.  In December 2007, a restaurant in Potter County illegally 
provided two jars of home-canned chicken soup to a patron, resulting in severe and prolonged 
paralysis of the patron.  Other jars of the improperly canned soup were recalled, and the joint on-
site investigation revealed additional deficiencies at the facility. Despite active surveillance, no 
other cases of botulism were identified.  Foodborne botulism remains very rare in Pennsylvania, 
with the last case reported in 2003.  
 
Cryptosporidium at a public pool  
Cryptosporidiosis is a diarrheal disease caused by parasitic protozoa of the genus 
Cryptosporidium.  Fecal-oral transmission of the parasite occurs via ingestion of contaminated 
drinking water, recreational water, or food, or through contact with infected persons or animals.  
Water is the most common mode of Cryptosporidium transmission and the parasite is one of the 
most frequent causes of waterborne disease among humans in the U.S.  Incidence usually peaks 
in late summer and coincides with the summer swimming season.  Recently, Cryptosporidium 
has been responsible for a number of waterborne outbreaks at swimming pools across the U.S.  
The Cryptosporidium parasite is protected by a hard outer shell, which allows it to survive 
outside the body for days and makes it very resistant to chlorine disinfection.  Because of its 
resistance to chlorination, Cryptosporidium has become the leading cause of gastroenteritis 
outbreaks associated with treated recreational water venues, accounting for an estimated 60% of 
the outbreaks reported to CDC between 1995 and 2004.  In addition, the incidence of 
cryptosporidiosis in the U.S. has more than doubled since 2004. 
In 2007, Pennsylvania had 939 confirmed cases of cryptosporidiosis; a case count that was much 
higher than the previous 4-year (2003−2006) average of 229 cases per year.  Most of the cases in 
2007 were the result of a series of outbreaks at swimming pools across southeastern 
Pennsylvania (mainly in Chester, Montgomery, and Philadelphia counties).  The first and largest 
outbreak, associated with a busy Chester County public pool, resulted in more than 300 cases 
beginning in late June and lasting into July.  Cases consisted of children and adults who had 
swum in the pool water, pool staff, and the parents and caregivers of infected children.  
Secondary transmission to other recreational water venues and contacts was observed.  Health 
officials with the Chester County Health Department investigated the outbreak and sent water 
samples to the state laboratory for testing.  Tests on the pool water came back positive for 
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norovirus and Giardia as well as Cryptosporidium.  In addition, both Giardia and 
Cryptosporidium were found in many of the stool samples from cases.  In order to halt further 
transmission of the parasite, infected persons were advised not to participate in recreational water 
activities until their gastrointestinal symptoms had ceased.  In addition, the pool was shut down 
by the health department on July 11 and the pool and surrounding areas were disinfected 
according to hyperchlorination protocols. 
In total, there were more than 700 outbreak-associated cases of Cryptosporidium in Pennsylvania 
in 2007.  These outbreaks underscore that conventional chlorination and filtration of recreational 
water facilities are inadequate to control cryptosporidiosis and transmission of recreational water 
illness.  Public health education should reinforce the notion that swimming pool patrons share 
responsibility for controlling the spread of Cryptosporidium in recreational water facilities and 
encourage the public to be proactive regarding the prevention of illness. 
 
Hantavirus at a youth camp 
In 2007, Pennsylvania had one confirmed case of hantavirus infection, in a man working at a 
Boy Scout camp in Clearfield County.  The individual was seriously ill in July, but recovered.  
He was exposed to wild rodents in a camp building, and the Department's on-site investigation 
revealed evidence of rodent infestation.  The camp took immediate steps to remediate the 
problem and was allowed to remain open.  Hantavirus is widely present in rural (but not urban) 
mice in the Commonwealth, but rarely causes disease in humans.  In the past decade, there were 
only three other cases of hantavirus infection confirmed in Pennsylvania.  The rodents 
themselves do not become ill, but excrete virus in their urine, feces and saliva.  There are no 
documented cases of person-to-person transmission of hantavirus in the U.S. 
 
Hepatitis B in a long-term care facility 
In June 2008, the PADOH received reports of an outbreak of acute hepatitis B virus (HBV) 
infection among residents of a long-term care facility and their contacts.  The outbreak occurred 
between March 2007 and April 2008.  In total, there were six cases of acute HBV infection, four 
of which were residents of the same assisted-living facility (ALF).  All of the cases were 60 
years of age or older and none of them had any traditional risk factors for HBV infection (i.e., 
intravenous drug use and high-risk sexual practices).  However, the six cases were clustered 
among diabetics who were undergoing blood glucose monitoring and receiving insulin injections 
that are part of routine medical care for diabetics. 
An epidemiologic investigation was conducted by the Department, along with the Centers for 
Disease Control and Prevention, which included observation of staff practices; interviews with 
administrators, staff, and cases; staff survey of infection-control practices; serology and 
molecular analysis of blood draws; and chart review and abstraction.  Lapses in recommended 
infection control practices were identified, including sharing of glucometers among residents 
without proper cleaning between each use, sharing of penlet fingerstick devices among residents, 
and failures perform proper hand hygiene or change gloves between each fingerstick procedure.  
In addition, investigators discovered that insulin was not drawn up using aseptic techniques and 
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blood/body fluid exposures were not being reported.  Further, the 85-bed facility employed only 
one licensed professional nurse who worked the day shift, meaning there were no professional 
nursing staff at the facility during evening or overnight shifts. 
The long incubation period for HBV infection, numerous percutaneous procedures that diabetics 
undergo, and difficulty in establishing the date of infection in persons with unrecognized or 
asymptomatic infection are among the difficulties encountered when trying to establish a specific 
mode of HBV transmission among residents of the facility.  Based on the cluster of HBV 
infections among diabetics and the sharing of penlet devices, it was concluded that blood glucose 
monitoring was the most likely mode of HBV transmission at the ALF.  In order to prevent 
further transmission, penlet devices were removed from the facility and replaced with single-use 
safety lancets, which staff were required to exclusively use.  In addition, new sharps containers 
were introduced, hepatitis B vaccinations were made available to staff, each diabetic resident 
was given their own glucometer, and in-service training was provided to staff.  Two of the 
infections resulted in chronic HBV infection, however there were no new cases reported beyond 
April 2008. 
 
Salmonella Schwarzengrund in dog food 
The PADOH collaborated with public health officials in other state health departments and 
federal agencies to investigate a multi-state outbreak of Salmonellaenterica serotype 
Schwarzengrund infections occurring between January 2006 and September 2008.  
Pennsylvania’s state public health laboratory first discovered that several cases of S. 
Schwarzengrund had an identical molecular subtyping pattern.  Infectious disease epidemiology 
staff then examined exposure histories for these cases, finding that a large proportion of them 
had had contact with dogs.  Additional samples collected from dog feces and bags of dry dog 
food were found to also contain the identical pattern of S. Schwarzengrund.  An expansion of the 
investigation found a total of 79 human cases of S. Schwarzengrund matching the outbreak 
pattern in 21 states.In total, 42% (33 cases) of the salmonellosis cases occurred in Pennsylvania.  
Dog food used by the cases was traced back to a pet food manufacturer in western Pennsylvania.  
Some environmental samples taken from the manufacturing plant also matched the outbreak 
subtype of S. Schwarzengrund.   
This is the first documented Salmonella outbreak associated with dry pet food.  Laboratory and 
epidemiologic evidence prompted the dog food manufacturer to close its manufacturing plant 
and announce a nationwide voluntary recall of all dry dog and cat food products produced during 
a 5-month period at one Pennsylvania plant.  Findings indicate that pet food is not a sterile 
product and pet owners must be aware of cross-contamination after feeding pets.  After handling 
pet foods, pet owners should wash their hands immediately and infants should be kept away from 
pet feeding areas. 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5744a2.htm 
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Measles at an international youth sporting event 
On August 16, 2007, a measles case was identified in a participant at an international youth 
sporting event in Pennsylvania.  The sporting event was held during August 17−26, 2007 and 
included eight US teams and eight international teams and had an estimated combined 
participant and spectator attendance of 265,000.  The patient had traveled from Japan while 
infectious, stopping in Detroit and Baltimore before finally reaching Williamsport, Pennsylvania.  
The PADOH⎯in collaboration with other states’ public health officials as well as federal 
agencies⎯conducted an investigation to determine the magnitude of the outbreak and to prevent 
further transmission.  Contact tracing was conducted among more than 1,300 exposed persons in 
eight states, including airplane passengers, airport workers, event staff and participants, hotel 
workers and guests.  A total ofseven measles cases in three states were identified in this 
outbreak.  The index patient had been exposed in Japan.  Two generations of secondary 
transmission were documented, including to an airplane passenger born before 1957 (persons 
born before 1957 are considered at low risk for measles), an airport worker, and two fully 
immunized college students.  One person was hospitalized and no deaths were reported.  In 
addition, 186 exposed persons without presumptive evidence of immunity were vaccinated.  
Viral genotyping (successful for six cases) identified measles genotype D5 and confirmed a 
single chain of transmission.  The two Pennsylvania cases were both imported from Japan.  
There were no secondary cases in Pennsylvania. 
Measles remains a highly infectious global disease.  It is no longer endemic in the US due to 
high coverage rates with an effective vaccine.  This importation-associated outbreak highlights 
the need to maintain high measles vaccination coverage in the US and to continue global control 
efforts.  Persons without documented measles immunity should receive appropriate vaccination. 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5707a1.htm 
Figure 26. Chain of measles transmission associated with an international youth 
sporting event outbreak, by date of exposure -- Michigan, Pennsylvania and Texas, 2007 
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SalmonellaTyphimurium in raw milk 
During February 2007 to July 2007 an outbreak of 29 cases of Salmonella enterica serotype 
Typhimurium occurred.  This pathogen had a rare Pulsed Field Gel Electrophoresis (PFGE) 
pattern and was associated with consumption of raw milk and unpasteurized cheese at a dairy in 
York County.  The PADOH and the Pennsylvania Department of Agriculture conducted an 
investigation to determine the source of the outbreak and to prevent further transmission.  
Among the 29 cases, the median age was 6 years with a range of 5 months to 76 years.  Fourteen 
(48%) reported having consumed raw milk from the dairy. Additionally, two (7%) had drunk raw 
milk of unknown origin; four (14%) had consumed a cheese made from raw milk; and two (7%) 
were infants living in households that had raw milk from the dairy present in the house.  The 
cheese from three of the four cheese-related cases was made from raw milk from the dairy; the 
traceback was unsuccessful in one case but the type of cheese was similar.  The S. Typhimurium 
outbreak strain was also isolated from raw milk obtained from the dairy and from two 
households of ill persons.  Although transmission was initially halted twice in March when raw 
milk sales were stopped, subsequent cases occurred after sales resumed.  A third cluster of cases 
occurred from June to July and was associated with unauthorized raw milk distribution from the 
same dairy. 
No new cases were identified after the Department of Agriculture revoked the raw milk permit 
from the dairy.  With an increase in Pennsylvania raw milk permits since 2005, the public should 
be informed about the health risks of raw milk consumption.  To prevent Salmonella and other 
infections, consumers should refrain from consumption of raw milk. 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5644a3.htm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Epidemic curve of Salmonella Typhimurium in raw milk outbreak, by 
number of cases and week of onset -- Pennsylvania, 
2007
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IV. TECHNICAL NOTES 
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TERMS AND DEFINITIONS: 
 
Sources of Data:  The Bureau of Communicable Diseases provided the Sexually Transmitted 
Disease and AIDS Data.  The Division of Infectious Disease Epidemiology provided all other 
reportable disease data that is submitted by health care providers and laboratories to the PA-
NEDSS data system.  The United States Census Bureau provided the data to calculate incidence 
rates.      
 
Population:All of the rate calculations in the report were done using Pennsylvania population 
estimates jointly created bythe Pennsylvania Bureau of Health Statistics and the Pennsylvania 
State Data Center.  These population estimates are created using the US Bureau of the Census 
population estimates as controls and then characteristics by age, sex, and race are created for the 
total Pennsylvania population and also for several select counties within the state.  The 
population estimates are as of July 1 for the intercensal years of 2003−2007.  All population data 
presented and/or used in this report are US Bureau of Census enumerated population figures as 
of April 1 of the Census year.   This information can be retrieved from the Census Bureau 
website at: http://www.census.gov/popest/counties/CO-EST2007-01.html. 
 
Case Definitions:  The case definition for each disease in this report is for public health 
surveillance purposes only.  It is not intended for use in clinical diagnosis.  Past and current CDC 
case definitions and classifications for each notifiable disease can be found on the CDC website 
at: http://www.cdc.gov/ncphi/disss/nndss/casedef/case_definitions.htm. 
 
Resident Data:  Data used in this report are compiled per usual residence regardless of the 
geographical place where the event occurred. 
 
Reliability of Rates:  Rates (or percentages) based on small numbers of events over a specified 
period of time or for a sparsely populated geographic area should be of particular concern and 
used cautiously.  There are many characteristics that can also render a crude rate of little use.  
Any unique demographic factors, such as those related to age and sex, may not be accounted for 
in crude rates.  This report did not adjust for age differences that may be seen between county, 
state, and national geographic areas. 
 
RATE FORMULAS: 
 
2007 Annual IncidenceRate: 
Total Reported Cases of Disease in PA for 2007     x  100,000  
Total PA Population for 2007 
 
 
Five-Year (2003−2007)Average Case Count (number of cases per year): 
Total Number of Reported Cases of Disease in PA (2003−2007) 
5 
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Five-Year (2003−2007)Average IncidenceRate:   
Average PA Case Count (2003−2007)x 100,000  
Average Population of PA from 2003−2007 
 
Crude Rate for Animal Rabies Cases:  The crude incidence rate was calculated using the 
human population, as it is unknown how many animals reside in a particular geographic area. 
 
 
 
DATA USED TO CALCULATE RATES: 
 
Table 5 describes the population data used to calculate disease rates by year and/or within 
specific age groups, by year (2003−2007). 
 
Table 5. Annual Estimates of the Population, by Year -- Pennsylvania, 2003−2007 
 
Population estimates as of July 1 
Age Group 
(years) 2003 2004 2005 2006 2007 
<1 146,541 145,947 145,062 144,079 148,577 
1−4 584,402 584,515 586,105 587,037 584,379 
5−9 784,728 776,098 771,098 766,023 759,157 
10−14 840,362 832,473 824,305 816,364 807,045 
15−19 904,628 918,572 924,662 928,078 926,505 
20−24 806,013 841,089 851,555 872,456 881,735 
25−29 714,304 709,838 713,188 724,247 731,050 
30−34 779,037 766,503 758,667 750,940 745,002 
35−39 878,567 864,583 847,463 831,606 814,379 
40−44 957,034 941,370 925,050 909,831 892,009 
45−49 939,911 940,220 937,258 933,337 924,342 
50−54 851,004 863,458 872,775 881,699 885,731 
55−59 708,599 733,292 754,819 773,648 788,216 
60−64 568,527 591,825 614,002 635,924 654,979 
65−69 496,734 500,203 507,418 525,622 530,978 
70−74 461,679 452,399 448,762 453,768 449,821 
75−79 408,944 397,526 391,283 390,065 380,896 
80−84 294,345 291,841 288,114 287,280 285,979 
≥85 240,096 254,540 268,030 228,617 242,012 
Total 12,365,455 12,406,292 12,429,616 12,440,621 12,432,792 
* PA 5-year (2003−2007) average population = 12,414,955 
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Table 6 describes the population data used to calculate disease rates within gender and specific 
age groups in 2007. 
 
Table 6. Annual Estimate of the Population, by Age Group and Gender -- Pennsylvania, 
2007 
Population estimates July 1, 2007 
Age Group 
(years) Male Female Total 
<1 75,969 72,608 148,577 
1−4 298,983 285,396 584,379 
5−9 388,260 370,897 759,157 
10−14 412,047 394,998 807,045 
15−19 466,767 459,738 926,505 
20−24 447,665 434,070 881,735 
25−29 373,619 357,431 731,050 
30−34 375,368 369,634 745,002 
35−39 404,922 409,457 814,379 
40−44 441,712 450,297 892,009 
45−49 455,938 468,404 924,342 
50−54 433,606 452,125 885,731 
55−59 381,553 406,663 788,216 
60−64 311,683 343,296 654,979 
65−69 243,480 287,498 530,978 
70−74 196,257 253,564 449,821 
75−79 154,666 226,230 380,896 
80−84 107,298 178,681 285,979 
≥85 68,871 173,141 242,012 
Total 6,038,664 6,394,128 12,432,792 
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Table 7 describes the population data used to calculate disease rates within each county in 2007. 
 
Table 7. Annual Estimate of the County Population -- Pennsylvania, 2007 
Population estimates July 1, 2007 
County Population County Population County Population 
Adams 100,779 Elk 32,610 Montour 17,817 
Allegheny 1,219,210 Erie 279,092 Northampton 293,522 
Armstrong 69,059 Fayette 144,556 Northumberland 91,003 
Beaver 173,074 Forest 6,955 Perry 45,163 
Bedford 49,650 Franklin 141,665 Philadelphia 1,449,634 
Berks 401,955 Fulton 14,939 Pike 58,633 
Blair 125,527 Greene 39,503 Potter 16,987 
Bradford 61,471 Huntington 45,556 Schuylkill 147,269 
Bucks 621,144 Indiana 87,690 Snyder 38,113 
Butler 181,934 Jefferson 45,135 Somerset 77,861 
Cambria 144,658 Juniata 23,168 Sullivan 6,200 
Cameron 5,349 Lackawanna 209,330 Susquehanna 41,123 
Carbon 63,242 Lancaster 498,465 Tioga 40,681 
Centre 144,658 Lawrence 90,991 Union 43,724 
Chester 486,345 Lebanon 127,889 Venango 54,763 
Clarion 40,028 Lehigh 337,343 Warren 40,986 
Clearfield 81,452 Luzerne 312,265 Washington 205,553 
Clinton 37,213 Lycoming 116,811 Wayne 51,708 
Columbia 64,726 McKean 43,633 Westmoreland 362,326 
Crawford 88,663 Mercer 116,809 Wyoming 27,835 
Cumberland 228,019 Mifflin 46,941 York 421,049 
Dauphin 255,710 Monroe 164,722   
Delaware 554,399 
 Montgomery 776,172 
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Table 8. Case Counting Definition Source and Case Classification Status of Reportable 
Infectious Diseases -- Pennsylvania, 2007 
Disease Case Definition Source and Status^ 
AIDS 1    C 
Amebiasis 1    C 
Anthrax 1    C 
Botulism, foodborne 1    C/P 
Botulism, infant 1    C 
Botulism, wound and unspecified 1    C 
Brucellosis 1    C/P 
Campylobacteriosis 1    C/P 
Chancroid 1    C/P 
Chickenpox (Varicella) 1    C/P 
Chlamydia trachomatis  1    C 
Cholera 1    C 
Coccidioidomycosis (Valley Fever) 1    C 
Creutzfeldt-Jakob disease 2    C 
Cryptosporidiosis 1    C 
Cyclosporiasis 1    C 
Dengue 1    C/P 
Diphtheria 1    C/P 
Ehrlichiosis, human granulocytic 1    C/P 
Ehrlichiosis, human monocytic 1    C/P 
Ehrlichiosis, unspecified 1    C/P 
Encephalitis, other arbovirus-related 1    C/P* 
Encephalitis, primary 1    C/P* 
Encephalitis, West Nile 1    C/P* 
Encephalitis, unspecified 1    C/P* 
Enterohemorrhagic E.coli, Shiga toxin-producing (combined E. coli O157:H7 and non-O157) 1    C/P/S* 
Enterohemorrhagic E. coli, group unknown 1    C/P/S* 
Giardiasis 1    C/P 
Gonococcal infections 1    C/P 
Granuloma inguinale 1    C 
Guillain-Barre syndrome 2    C 
Haemophilis influenzae invasive disease 1    C/P 
Hantavirus pulmonary syndrome 1    C 
Hemolytic Uremic Syndrome (HUS) 1    C/P 
Hepatitis A, acute 1    C 
Hepatitis B, acute 1    C 
Hepatitis B, chronic 1    C/P+ 
Hepatitis B, perinatal 1    C 
Hepatitis C, acute 1    C* 
Hepatitis C, past or present infection 1    C/P* 
Hepatitis D 2    C 
Hepatitis E 2    C 
Histoplasmosis 2    C 
HIV (Human immunodeficiency virus) 1    C 
Influenza A 2    C/P 
Influenza B 2    C/P 
Influenza, unspecified 2    C/P 
Kawasaki syndrome 1    C 
Legionellosis 1    C/S# 
Leprosy (Hansen’s disease) 1    C 
Leptospirosis 1    C/P 
Listeriosis 1    C 
Lyme disease 1    C 
Lymphogranuloma venereum 1    C/P 
Malaria 1    C 
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Measles (Rubeola) 1    C/P/S* 
Meningitis, aseptic 1    C 
Meningitis, other 1    C 
Meningococcal invasive disease (Neisseria meningitides) 1    C/P/S^^ 
Mumps 1    C/P 
Pertussis (whooping cough) 1    C/P 
Plague (Yersinia pestis) 1    C/P/S 
Poliomyelitis 1    C/P 
Psittacosis (ornithosis) 1    C/P 
Q fever (Coxiella burnetii infection) 1    C/P 
Rabies, animal 1    C 
Rabies, human 1    C 
Respiratory syncytial virus 2    C/P 
Rickettsial infections, other and unspecified 1    C/P* 
Rocky Mountain spotted fever 1    C/P* 
Rubella (German measles) 1    C/P/S* 
Rubella, congenital syndrome 1    C/P/S 
Salmonellosis 1    C/P* 
Severe Acute Respiratory Syndrome (SARS) 1    C/P 
Shigellosis 1    C/P* 
Smallpox 1    C/P/S++ 
Staphylococcal aureus, vancomycin-resistant invasive disease (VRSA) 1    C*++ 
Staphylococcal aureus, vancomycin intermediate invasive disease (VISA) 1    C*++ 
Streptococcal invasive disease (Group A) 1    C 
Streptococcus pneumoniae, drug resistant invasive disease 1    C/P* 
Syphilis, congenital 1    C/P 
Syphilis, early latent 1    P 
Syphilis, late latent 1    P 
Syphilis, neuro 1    C/P 
Syphilis, primary and secondary 1    C/P 
Syphilis, primary 1    C/P 
Syphilis, secondary 1    C/P 
Syphilis, unknown latency 1    P 
Tetanus 1    C 
Toxic shock syndrome, other 1    C/P 
Toxic shock syndrome, streptococcal 1    C/P 
Toxoplasmosis 2    C/P 
Trichinellosis 1    C 
Tuberculosis 1    C 
Tularemia 1    C/P 
Typhoid fever 1    C/P 
Vibriosis, non-cholera 1    C/P** 
West Nile fever 1    C/P* 
Yellow fever 1    C/P 
1  CDC case definition and classification (CDC, 2009) 
2  No CDC print policy/case definition  
^ Case classifications: C=confirmed, P=probable, S=suspect 
* Case definition changed between 2003 and 2007, with no change in case classification. 
+ Case classification changed from C prior to 2007 to C or P in 2007. 
# Case classification changed from C prior to 2005 to C or S in 2005. 
^^ Case classification changed from C or P prior to 2005 to C, P, or S in 2005. 
++ Information was not collected prior to 2004. 
** Information was not collected prior to 2007. 
 
  
 
